Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

Journal of Child and Adolescent Psychopharmacology

Volumn 8, Issue 3, 1998, Pages 151-159

  Kelly, Deanna L ^a   Conley, Robert R ^a,b   Love, Raymond C ^b   Horn, David S ^c   Ushchak, Catherine M ^c  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Reg Inst for Children/Adolescents

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; HALOPERIDOL; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; PERPHENAZINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE;

ADOLESCENT; ADULT; AFFECTIVE NEUROSIS; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR DISORDER; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MALE; OBESITY; PERSONALITY DISORDER; PSYCHOSIS; SCHOOL CHILD; WEIGHT GAIN;

EID: 0031740445     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1998.8.151     Document Type: Article

References (24)

1. Anderson C, Clark WR, True J, Ereshefsky L, Miller A: Risperidone, a novel antipsychotic, and weight change [Abstract]. Pharmacotherapy 13:292, 1993
2. Armenteros JL, Whitaker AH, Welikson M, Stedge DJ, Gorman J: Risperidone in adolescents with schizophrenia: An open pilot study. J Am Acad Child Adolescent Psychiatry 26:694-700, 1997
3. Billewicz WZ, Kemsley FF, Thompson AM: Indices of adiposity. Br J Prev Soc Med 16:183-188, 1962
4. Bray GA, Davidson MB, Drenick EJ: Obesity: A serious symptom. Ann Intern Med 77:779-795, 1972
5. Cohen S, Chiles J, MacNaughton A: Weight gain associated with clozapine. Am J Psychiatry 147:503-504, 1990
6. Depres JP, Moorjani S, Lupien PJ, Tremblay A, Naudeau A, Bouchard C: Regional distribution of body fat, plasma liproproteins, and cardiovascular disease. Arteriosclerosis 10:497-511, 1990
7. Guo SS, Roche AF, Cameron Chumlea W, Gardner JD, Siervogel RM: The predictive value of childhood body mass index values for overweight at age 35 years Am J Clin Nutr 59:810-819, 1994
8. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM: Physical growth: National center for health statistics percentiles. Am J Clin Nutr 32:607-629, 1979
9. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM: Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 145:259-263, 1991
10. Harris E, Eth S: Weight gain during neuroleptic treatment. Int J Nursing Studies 18:171-175, 1981
11. Hoffmans MDAF, Kromhout D, de Lezenne Coulander C: Body mass index at the age of 18 and its effects on 32-year-mortality from coronary heart disease and cancer. J Clin Epidemiol 42:513-520, 1989
12. Johnson DAW, Breen M: Weight changes with depot neuroleptic maintenance therapy. Acta Psychiatr Scand 59:525-528, 1979
13. Kalucy RS: Drug-induced weight gain. Drugs 19:268-278, 1980
14. Klett CJ, Caffey EM Jr: Weight changes during treatment with phenothiazine derivatives. J Neuropsychiatry 2:102-108, 1960
15. Kumra S, Heron D, Jacobsen LK, Briguglia C, Grothe D: Case study: Risperidone-induced hepatotoxicity in pediatric patients. J Am Acad Child Adolesc Psychiatry 36:701-705, 1997
16. Lamberti JS, Bellnier T, Schwarzkopf SB: Weight gain among schizophrenic patients treated with clozapine. Am J Psychiatry 149:689-690, 1992
17. Leadbetter R, Shutty M, Pavalonis D, Vieweg V, Higgins P, Downs M: Clozapine-induced weight gain: Prevalence and clinical relevance. Am J Psychiatry 149:68-72, 1992
18. Lombroso PJ, Scahill L, King RA, et al.: Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report. J Am Acad Child Adolesc Psychiatry 34:1147-1152, 1995
19. Marriott P, Pansa M, Hiep A: Depot fluphenazine maintenance treatment and associated weight changes. Comprehensive Psychiatry 22:320-325, 1981
20. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH: Long-term morbidity and mortality of overweight adolescents: A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 327:1350-1355, 1992
21. Penn JV, Martini J, Radka D: Weight gain associated with risperidone. J Clin Psychopharmacol 16:259-260, 1996
22. Perry R, Pataki C, Munoz-Silva DM, Armenteros J, Silva RR: Risperidone in children and adolescents with pervasive developmental disorder: Pilot trial and follow-up. J Child Adolescent Psychopharmacol 7:167-179, 1997
23. Schertz M, Adesman AR, Alfieri NE, Bienkowski RS: Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics 98:763-769, 1996
24. Van Itallie TB: Obesity: Adverse effects on health and longevity. Am J Clin Nutr 32:2723-2733, 1979